investor login

contact

team

dedicated funds

news

 portfolio

Provider of genomic and biomedical computing platform intended to empower scientists and clinicians to focus on making breakthrough discoveries and delivering real-world care. The company’s genomic and biomedical computing platform enables patient-level genomic and health data to be securely accessible for drug development and precision medicine, enabling scientists and clinicians to manage, process, analyze and share massive biomedical data sets for everything from genomics to imaging.

 

Acquired by Veritas Genetics in August 2017.
 
VISIT WEBSITE

Exited, Health Tech, HVP IV

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio